Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 351 - 400 out of 5,712

Document Document Title
WO/2020/178404A1
The present invention relates to herbicidally active pyridazine derivatives of Formula (I) as defined herein, as well as to herbicidal compositions comprising such derivatives, and the use of such compounds and compositions for controlli...  
WO/2020/176505A1
The present disclosure relates generally to certain diacylglycerol lactone compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds an...  
WO/2020/175688A1
[Problem] To provide a fluorescent probe capable of detecting breast cancer, lung cancer, and squamous cell cancer. [Solution] A fluorescent probe for detecting breast cancer and benign tumors of the breast, the probe containing a compou...  
WO/2020/172258A1
Disclosed herein are compounds and compositions having potency in the modulation of Myc family proteins. Such compounds and compositions can be used in the treatment of proliferative diseases, such as cancer, or in the treatment of disea...  
WO/2020/168149A1
Disclosed are compounds of Formula (I): or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt or solvate thereof, wherein Q is: (i) halo, cyano, hydroxyl, NRxRx, C(O)OH, C(O)NH2, C1-6 alkyl substituted with zero to 6 R1a, ...  
WO/2020/166875A1
The present invention provides a novel compound and an organic light emitting device using same.  
WO/2020/166874A1
The present invention provides a novel compound and an organic light-emitting diode using same.  
WO/2020/156363A1
The present application discloses an immunomodulator, and specifically discloses a compound depicted by formula (I), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound provided in the present applicati...  
WO/2020/159019A1
The present invention relates to a novel organic light-emitting compound and an organic electroluminescent device using same and, more specifically, to a compound having excellent thermal stability, electrochemical stability, light-emitt...  
WO/2020/158958A1
The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof has an orexi...  
WO/2020/152067A1
Compounds of the formula (I): Q1-Q2-Q3, in which Q1, Q2 and Q3 have the meanings indicated in Claim 1, degrade target proteins, and can be employed, inter alia, for the treatment of diseases such as cancer, multiple sclerosis, cardiovasc...  
WO/2020/151623A1
The present invention pertains to the medical field and relates to a compound of formula (III), a stereoisomer or pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the compound, a ster...  
WO/2020/151621A1
The present invention belongs to the field of medicine, and specifically relates to a compound of formula (I), an isomer or a pharmaceutical salt thereof. This present invention more specifically relates to a compound, a stereoisomer the...  
WO/2020/153669A1
The present invention relates to a compound for an organic electric device, an organic electric device using same, and an electronic apparatus thereof. According to the present invention, high luminous efficiency, low driving voltage, an...  
WO/2020/135427A1
The present invention relates to a monomer compound represented by formula (I), wherein each variable is as defined in the description. The described monomer is quickly synthesized at a high yield by means of a click chemistry reaction b...  
WO/2020/139001A1
The present invention provides a novel aryl-substituted aminomethyloxetenyl amino alcohol derivative or a pharmaceutically acceptable salt thereof. More specifically, the derivative has an effect of promoting ATP production and as such, ...  
WO/2020/135872A1
Provided are a drug, a pharmaceutical composition, or a pharmaceutical kit for immunosuppression, for the treatment of conditions such as psoriasis, comprising a forskolin derivative or a salt thereof and optionally a prostaglandin compo...  
WO/2020/138732A1
The present invention provides: a compound represented by chemical formula 1; an organic electric device comprising a first electrode, a second electrode, and an organic material layer between the first electrode and the second electrode...  
WO/2020/134138A1
The present disclosure relates to the technical field of luminescent materials, and relates in particular to an organic electroluminescent compound, a preparation method therefor and an organic electroluminescent device. In order to solv...  
WO/2020/131689A1
Provided herein is a compound of Formula (I), or a salt thereof, wherein R1 is a moiety having the following structure: (II) wherein Z is selected from the group consisting of O and N; X is selected from the group consisting of a bond, N...  
WO/2020/127259A2
The present application concerns compounds for use in electronic devices, processes for preparing the compounds, and electronic devices comprising the compounds.  
WO/2020/127194A1
Anticancer compounds of formula (I) and derivatives thereof are provided.  
WO/2020/132278A1
The present invention concerns the use of compounds and compositions for the treatment or prevention of Flavivirus infections, such as dengue virus infections and Zika virus infections. Aspects of the invention include methods for treati...  
WO/2020/127200A1
The present invention relates to a compound of formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, cocrystal, tautomer, racemate, enantiomer, or diastereomer or mixture thereof Formula (I) and to pharmaceu...  
WO/2020/130102A1
Antibody preparations for improving or treating autoimmune diseases have been proposed, but the route of administration is limited to intravenous, imposing a burden on the patient. Also, mangiferin has an effect for improving autoimmune ...  
WO/2020/120528A1
The present invention provides the compounds having the general formula: (I) wherein R1 to R8, and X are as described herein, compositions including the compounds and methods of using the compounds.  
WO/2020/122908A1
An electrochromic medium for use in an electro-optic device comprises a solvent comprising at least one low-volatile organic electrolyte solvent based on a cyclic carbonate ester; an anodic electroactive material; and a cathodic electroa...  
WO/2020/117894A1
Enantioselective total syntheses of the anticancer isocarbostyril alkaloids (+)-7-deoxypancratistatin, (+)-pancratistatin, (+)-lycoricidine, and (+)-narciclasine are described. Our strategy for accessing this unique class of natural prod...  
WO/2020/118116A1
The present disclosure provides NIR- and SWIR-active small molecule polymethine dyes with improved properties for use in optical imaging, photothermal therapy, and photodynamic therapy.  
WO/2020/110008A1
The disclosure relates to inhibitors of PCSK9 useful in the treatment of cholesterol lipid metabolism, and other diseases in which PCSK9 plays a role, having the Formula (I):, or a pharmaceutically acceptable salt, hydrate, solvate, prod...  
WO/2020/111613A1
The present invention provides a novel compound and an organic light-emitting diode using same.  
WO/2020/111602A1
The present invention provides a novel compound and an organic light-emitting element using same.  
WO/2020/111586A1
The present invention provides a novel compound and an organic light-emitting device using same.  
WO/2020/111584A1
The present invention provides a novel compound and an organic light emitting diode using same.  
WO/2020/111601A1
The present invention provides a novel compound and an organic light-emitting device using same.  
WO/2020/111780A1
The present invention provides a novel compound and an organic light emitting device using same.  
WO/2020/111585A1
The present invention provides a novel compound and an organic light-emitting device using same.  
WO/2020/111673A1
The present invention provides a novel compound and an organic light emitting diode using same.  
WO/2020/111225A1
Provided are: a triazine compound having a high glass transition temperature, the triazine compound contributing to the formation of an organic electroluminescent element that exhibits high luminous efficiency and long service life chara...  
WO/2020/106028A1
The present specification provides a compound represented by chemical formula 1 and an organic light-emitting device comprising same.  
WO/2020/106102A1
The present specification relates to a compound of chemical formula 1 and an organic light emitting diode comprising same.  
WO/2020/087694A1
The present invention relates to a substituted nitrogen-containing heterocyclic formamide derivative, a weeding composition and the uses thereof. The substituted nitrogen-containing heteroaromatic ring formamide derivative has a structur...  
WO/2020/091446A1
The present disclosure relates to an organic electroluminescent compound and an organic electroluminescent device comprising the same. By comprising the organic electroluminescent compound according to the present disclosure, an organic ...  
WO/2020/085797A1
The present invention relates to a compound for an organic electric element, an organic electric element using same, and an electronic device thereof. According to the present invention, high light-emitting efficiency, low driving voltag...  
WO/2020/085845A1
The present disclosure relates to an organic electroluminescent compound and an organic electroluminescent device comprising the same. The organic electroluminescent compound of the present disclosure may be comprised in a light-emitting...  
WO/2020/079173A1
The present disclosure relates to fungicidal active compounds, more specifically to pyridylphenylaminoquinolines and analogues thereof, processes and, intermediates for their preparation and use thereof as fungicidal active compound, par...  
WO/2020/073985A1
The invention provides a crystalline structure of mu opioid receptor (MOR) agonist and a preparation method therefor. Specifically, the invention provides (1S4S)-4-ethoxy-N-(2-((R)-9-(pyridine-2-yl)-6-oxaspiro [4.5] decano-9-yl) ethyl) -...  
WO/2020/070088A1
The present invention provides novel compounds having the general formula (Formula I) : wherein R1 to R6, G1, G2, A1 to A4 and m are as described herein, compositions including the compounds and methods of using the compounds.  
WO/2020/071550A1
The present invention provides a novel CDK8 inhibitor. The present invention relates to: a compound represented by general formula (I) (wherein the symbols are as defined in the description) or a pharmaceutically acceptable salt thereof;...  
WO/2020/072695A1
3-Carbonylamino-8-aminoisoquinoline compounds of formula (I): variations thereof, and their use as inhibitors of HPK1 (hematopoietic kinase 1) are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an ...  

Matches 351 - 400 out of 5,712